page_head_bg

Products

Rapid Delivery for 9,10-Dimethoxyptercarpan-3-O-β-D-glucoside - Verbascoside CAS No. 61276-17-3 – Yongjian

Short Description:


Product Detail

Product Tags

Related Video

Feedback (2)

To be a result of ours specialty and service consciousness, our enterprise has won an excellent status between buyers all around the globe for Cas No.20633-67-4 , Cas No.484-76-4 okanin , Cas No.548-83-4 Galangin , Please don't hesitate to contact us if you are interested in our products. We firmly believe our products will make you satisfied.
Rapid Delivery for 9,10-Dimethoxyptercarpan-3-O-β-D-glucoside - Verbascoside CAS No. 61276-17-3 – Yongjian Detail:

Essential Information

[name] Mullein glycoside

[alias] ergosterol, Mullein

[category] phenylpropanoid glycosides

[English name] acteoside; Verbascoside; Kusaginin

[molecular formula] C29H36O15

[molecular weight] 624.59

[CAS No.] 61276-17-3

Physicochemical Properties

[properties] this product is white needle crystal powder

[relative density] 1.6g/cm3

[solubility] easily soluble in ethanol, methanol and ethyl acetate.

Extraction Source

This product is the dry fleshy stem with scaly leaves of Cistanche deserticola, a plant of liedang family.

Test Method

HPLC ≥ 98%

Chromatographic conditions: mobile phase methanol acetonitrile 1% acetic acid (15:10:75), flow rate 0.6 ml · min-1, column temperature 30 ℃, detection wavelength 334 nm (for reference only)

Function and Use

This product is used for content determination

Storage Method

2-8 ° C, stored away from light.

Bioactivity of Verbascoside

In Vitro Study:

As a competitive PKC Inhibitor of ATP, Verbascoside has an IC50 of 25 μ M。 Verbascoside showed kis of 22 and 28 relative to ATP and histone, respectively μ M。 Verbascoside has effective antitumor activity on L-1210 cells with IC50 of 13 μ M[1]。 Verbascoside (5,10) μ M) Inhibition of 2,4-dinitrochlorobenzene (DNCB) – induced T cell costimulatory factors CD86 and CD54, proinflammatory cytokines and NF in thk-1 cells κ B pathway activation [2].

In Vivo Studies:

Verbascoside (1%) reduced the incidence of overall scratching behavior and the severity of skin lesions in a mouse model of 2,4-dinitrochlorobenzene (DNCB) – induced atopic dermatitis (AD). Verbascoside can also block the pro-inflammatory cytokine TNF in DNCB induced skin lesions- α, Expression of IL-6 and IL-4 mRNA [2]. Verbascoside (50100 mg / kg, IP) did not change the cold abnormal pain caused by chronic compressive injury (CCI). Verbascoside(200 mg / kg, IP) reduced allergy to cold stimulated acetone on day 3. Verbascoside also significantly reduced the behavioral changes associated with neuropathy. In addition, Verbascoside reduced Bax and increased Bcl-2 on day 3 [3].

Cell Experiment:

lymphocytic mouse leukemia L1210 cells (ATCC, CCL 219) contained 10% fetal bovine serum, 4 mM glutamine, 100 U / ml penicillin, 100 μ In the 24 well cluster plate of Dulbecco modified Eagle medium, 104 cells per well were sparsely laid/ Ml streptomycin sulfate and Verbascoside (dissolved in DMSO). Growth was monitored by counting the number of cells in the Coulter counter after 2 days of incubation in a humid atmosphere (5% CO2 in air) at 37 ℃. The IC50 value was calculated based on the linear regression line established for each test compound [1].

Animal Experiment:

In order to induce atopic dermatitis (AD) – like symptoms, rats [2] used 2,4-dinitrochlorobenzene (DNCB). In short, the dorsal hair of mice was removed with electronic scissors 2 days before DNCB treatment. Will 200 μ L of 1% DNCB (in acetone: olive oil = 4:1) was applied to shaved back skin for sensitization. Repeated attacks were performed at the same site, 0.2% DNCB every 3 days for about 2 weeks. Mice were divided into 4 groups (n = 6 in each group): (1) vehicle treated control, (2) DNCB treated only, (3) 1% Verbascoside (acetone: olive oil 4:1) – treated only, and (4) DNCB + 1% Verbascoside treated group[2].

Reference:

[1]. Herbert JM, et al. Verbascoside isolated from Lantana camara, an inhibitor of protein kinase C. J Nat Prod. 1991 Nov-Dec;54(6):1595-600.

[2]. Li Y, et al. Verbascoside Alleviates Atopic Dermatitis-Like Symptoms in Mice via Its Potent Anti-Inflammatory Effect. Int Arch Allergy Immunol. 2018;175(4):220-230.

[3]. Amin B, et al. The Effect of Verbascoside in Neuropathic Pain Induced by Chronic Constriction Injury in Rats. Phytother Res. 2016 Jan;30(1):128-35.


Product detail pictures:

Rapid Delivery for 9,10-Dimethoxyptercarpan-3-O-β-D-glucoside - Verbascoside CAS No. 61276-17-3 –  Yongjian detail pictures


Related Product Guide:

We persist with the principle of "quality 1st, assistance initially, continual improvement and innovation to meet the customers" for your management and "zero defect, zero complaints" as the standard objective. To great our service, we present the products and solutions while using the very good top quality at the reasonable cost for Rapid Delivery for 9,10-Dimethoxyptercarpan-3-O-β-D-glucoside - Verbascoside CAS No. 61276-17-3 – Yongjian , The product will supply to all over the world, such as: Mombasa, Colombia, Colombia, They are sturdy modeling and promoting effectively all over the world. Never ever disappearing major functions within a quick time, it's a have to in your case of fantastic good quality. Guided by the principle of "Prudence, Efficiency, Union and Innovation. the corporation. ake an excellent efforts to expand its international trade, raise its organization. rofit and raise its export scale. We have been confident that we've been going to have a bright prospect and to be distributed all over the world in the years to come.
  • With a positive attitude of "regard the market, regard the custom, regard the science", the company works actively to do research and development. Hope we have a future business relationships and achieving mutual success.
    5 Stars By Gill from Algeria - 2017.10.23 10:29
    The enterprise has a strong capital and competitive power, product is sufficient, reliable, so we have no worries on cooperating with them.
    5 Stars By Dale from Benin - 2017.04.18 16:45
    Write your message here and send it to us